New Chimeric Peptides Enhance Antimicrobial Properties of HBDs
This invention exploits the remarkable differences in the antimicrobial properties shown by human beta-defensins 2 and 3 (HBD2 and HBD3) against Gram-positive and Gram-negative bacteria through the generation of chimeric molecules of HBD2 and HBD3 with improved activity against E.coli and S.aureus strains compared to wild-type. The chimeras are very interesting novel molecules, based on the natural human proteins, which offer a combined and improved defensin activity.
Further Information: PDF
Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937
Contact
Dr. Alexandra Baumgartner
